Jump to navigation
The latest clinical and political news for Australian Cardiologists
New recommendations include mandatory screening in all patients over 65
Aussie research finds big differences between warfarin and NOACs
Adding ezetimibe to the mix does not result in better outcomes in acute coronary syndrome
A smartphone game motivates participation in cardiac rehab
It should help doctors and patients make informed decisions.
The CHA2-DS2-VASc leads to too much anticoagulation in low-risk patients, they say.
For cardiologists this year, all roads led to Rome
Widely used risk score puts too many people on anticoagulation therapy
Their latest guidelines call for lifestyle interventions on a population level
Patients feel less tired, but there is no benefit to heart health
ESC 2016 delegates were surprised to hear its use is routine in Australia
In most cases they cause less intracranial bleeding than warfarin
Coronary procedures are likely playing a bigger role than medication.
It's being misused in up to one-third of AF patients who are eligible for oral anticoagulants.
Other cases might emerge, health authorities say.
There’s no evidence of its benefit in low and intermediate risk patients, says Aussie surgeon
We talk to Dr Charles Pollack about the recently approved dabigatran reversal agent
It’s the next big thing in cardiovascular disease but where are the treatments?
Switching to a NOAC shouldn’t be automatic, he says
GPs are best placed to do this, say two specialists
Australian Doctor Group is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.
Ensure you never miss a big story by signing up for our daily e-newsletter.